326030.KS
SK Biopharmaceuticals Co., Ltd.
KSC · Healthcare · Biotechnology · KR
KRW 86,400.00
+0.12%Margins
Gross margin
91.9%
EBITDA margin
27.4%
EBIT margin
35.2%
Net margin
46.6%
FCF margin
28.3%
39.2%
Return on equity
28.3%
Return on assets
28.3%
Return on invested capital
0.63x
Asset turnover
KRW 251.6B
Cash from operations
KRW 5.0K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026